Antibiotics and Activity Spaces: An Exploratory Study of Behaviour, Marginalisation, and Knowledge Diffusion

NCT03241316 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5885

Last updated 2018-11-07

No results posted yet for this study

Summary

The investigators will conduct two rural surveys in Thailand and Lao PDR to improve the understanding of antibiotic-related health behaviour among the general population. One survey will capture a cross-section of health behaviours that is representative for the rural population in Chiang Rai (Thailand) and Salavan (Lao PDR), the other survey will create a two round village-level panel data set to study the evolution of health behaviours in the context of public engagement activities. The investigators will also collect complementary data about village-level infrastructure through observational check-lists, and collect secondary data on patient load from primary care units catering to their survey villages. As part of the questionnaire testing process, the investigators will conduct (and collect as primary data) cognitive interviews to improve the survey tool, to interpret their data, and to justify their methodological choices.

Conditions

  • Antibiotic Use
  • Rural Healthcare-seeking Behaviour
  • Marginalisation (Economic, Social, Spatial)

Interventions

BEHAVIORAL

Observational study of behaviour

As a general population survey, our study does not involve a control group. Please note that the investigators do not interview patients; we involve only healthy members of the general public who consider themselves fit to be interviewed.

Sponsors & Collaborators

  • Mahidol Oxford Tropical Medicine Research Unit

    collaborator OTHER
  • Economic and Social Research Council, United Kingdom

    collaborator OTHER
  • Mae Fah Luang University

    collaborator OTHER
  • University of Oxford

    lead OTHER

Principal Investigators

  • Marco Haenssgen, Dr. · Mahidol Oxford Tropical Medicine Unit

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2018-05-31
Completion
2018-10-31

Countries

  • Laos
  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03241316 on ClinicalTrials.gov